How Antimicrobial Peptides Destroy Bacterial Membranes — and Why They Work Better Together

This is a review incorporating published and unpublished biophysical data. Techniques include solid-state NMR, molecular dynamics simulations, microscopic imaging of bacterial cells, and new experiments using isothermal titration calorimetry (ITC), circular dichroism (CD), and dynamic light scattering (DLS) to study peptide-membrane and peptide-peptide interactions in model lipid systems.

With antibiotic resistance rising globally, antimicrobial peptides are being explored as alternatives to conventional antibiotics. Understanding exactly how these peptides physically destroy bacterial membranes — and how combining them amplifies the effect — is essential for developing them as therapeutics. The synergy findings are particularly valuable because synergistic combinations could work at lower individual doses, reducing potential toxicity.

Antimicrobial peptides represent one of the most promising alternatives to conventional antibiotics in an era of growing drug resistance. This work deepens the mechanistic understanding of how these peptides work at the membrane level and reveals that synergistic peptide combinations may operate through membrane agglutination — a finding that could inform the design of combination peptide therapies.

Most experiments were conducted with model lipid membranes (liposomes) rather than intact bacterial cells, which have more complex membrane compositions. The SMART model is descriptive rather than predictive. The synergy mechanisms demonstrated in vitro would need validation in bacterial killing assays and animal models. The review focuses primarily on cationic linear peptides and may not generalize to all antimicrobial peptide classes.